Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Nasopharyngeal Carcinoma 59Squamous Cell Carcinoma of Head and Neck 55Head and Neck Neoplasms 55Prostatic Neoplasms 40Oropharyngeal Neoplasms 24Carcinoma, Non-Small-Cell Lung 23Carcinoma, Squamous Cell 21Rectal Neoplasms 19Breast Neoplasms 19Nasopharyngeal Neoplasms 14Neoplasm Metastasis 13Glioblastoma 13Carcinoma 13Esophageal Neoplasms 12Uterine Cervical Neoplasms 11Pancreatic Neoplasms 11Lung Neoplasms 11Glioma 11Esophageal Squamous Cell Carcinoma 11Sarcoma 9Radiation Injuries 8Neoplasms 8Laryngeal Neoplasms 8Brain Neoplasms 8Urinary Bladder Neoplasms 7Tongue Neoplasms 7Mouth Neoplasms 7Hypopharyngeal Neoplasms 7Carcinoma, Hepatocellular 6Astrocytoma 6

Interventions

Vincristine 4Etoposide 4Doxorubicin 4Cyclophosphamide 4Thiotepa 3Temozolomide 3Ifosfamide 3Filgrastim 3Cisplatin 3fludarabine phosphate 2Radiotherapy 2Melphalan 2Irinotecan 2Hyperthermic Intraperitoneal Chemotherapy 2Granulocyte Colony-Stimulating Factor 2Cytoreduction Surgical Procedures 2Brachytherapy 2thymoglobulin 1temsirolimus 1sodium thiosulfate 1prexasertib 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1pazopanib 1pasireotide 1fludarabine 1Zoledronic Acid 1X-Rays 1Topotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Desmoplastic Small Round Cell Tumor × Radiotherapy, Intensity-Modulated × Clear all
NCT04022213 2025-07-20

A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
31 enrolled

Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡